Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VITAMIN D NOS Cause Transient ischaemic attack? 11 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Transient ischaemic attack have been filed in association with VITAMIN D NOS. This represents 0.4% of all adverse event reports for VITAMIN D NOS.

11
Reports of Transient ischaemic attack with VITAMIN D NOS
0.4%
of all VITAMIN D NOS reports
8
Deaths
10
Hospitalizations

How Dangerous Is Transient ischaemic attack From VITAMIN D NOS?

Of the 11 reports, 8 (72.7%) resulted in death, 10 (90.9%) required hospitalization, and 8 (72.7%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VITAMIN D NOS. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does VITAMIN D NOS Cause?

Asthma (646) Dyspnoea (617) Wheezing (600) Therapeutic product effect incomplete (495) Drug ineffective (483) Pain (377) Sleep disorder due to a general medical condition (347) Obstructive airways disorder (309) Fatigue (304) Cough (299)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which VITAMIN D NOS Alternatives Have Lower Transient ischaemic attack Risk?

VITAMIN D NOS vs VITAMINS VITAMIN D NOS vs VOCLOSPORIN VITAMIN D NOS vs VOGLIBOSE VITAMIN D NOS vs VOLTAREN VITAMIN D NOS vs VON WILLEBRAND FACTOR

Related Pages

VITAMIN D NOS Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack VITAMIN D NOS Demographics